× Key messages Background Findings Perspectives Expert commentary
Home Font size Night/Day Mode Index

Perspectives

How does this study impact clinical practice?

  • AHCL therapy achieved high %TIR with low %TBR (time below range) in this study in patients with T1D.
  • With a set point of 100 mg/dL and an AIT (active insulin time) setting of 2-3 hours, nearly 80% of participants achieved a TIR70-180 >70% without an increase in hypoglycemia.
  • AHCL therapy further improved glycemia control.